Athersys, Inc. Gains 32.67%
Wed, Apr 01, 2020 at 05:30 PM
Athersys, Inc. (ATHX:NASDAQ) soared at $3.98, representing a gain of 32.7%. On Tue 31 Mar 20, ATHX:NASDAQ touched a New 2-Week High of $3. The stock appeared on our News Catalysts scanner on Mon 30 Mar 20 at 06:49 AM in the 'ACQUISITION' category. From Tue 17 Mar 20, the stock recorded 60.00% Up Days and 63.64% Green Days
About Athersys, Inc. (ATHX:NASDAQ)
Athersys Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.
Top 10 Gainers:
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 61.09%
- InflaRx N.V. (IFRX:NASDAQ), 50%
- Dynatronics Corporation (DYNT:NASDAQ), 48.2%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 43.41%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 42.38%
- Chembio Diagnostics, Inc. (CEMI:NASDAQ), 39.84%
- Citius Pharmaceuticals, Inc. (CTXR:NASDAQ), 36.64%
- Boxlight Corporation (BOXL:NASDAQ), 35.46%
- Safe-T Group Ltd (SFET:NASDAQ), 32.93%
- Athersys, Inc. (ATHX:NASDAQ), 32.67%